|
|
|
Volumn 26, Issue 4 SUPPL. 12, 1999, Pages 11-20
|
|
Recent developments in breast cancer therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 ETHYNYLURACIL;
ANTHRACYCLINE ANTIBIOTIC AGENT;
CAPECITABINE;
CYTOTOXIC AGENT;
DOCETAXEL;
DOXORUBICIN;
EDATREXATE;
FOLIC ACID ANTAGONIST;
GEMCITABINE;
LOSOXANTRONE;
NAVELBINE;
ORZEL;
PACLITAXEL;
TAXANE DERIVATIVE;
TELOXANTRONE;
THYMIDYLATE SYNTHASE INHIBITOR;
UFT;
UNCLASSIFIED DRUG;
VINCA ALKALOID;
ANGIOGENESIS;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER THERAPY;
CELL IMMORTALIZATION;
DRUG EFFICACY;
EARLY DIAGNOSIS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GENE THERAPY;
HORMONAL THERAPY;
HUMAN;
MAMMOGRAPHY;
OSTEOCLAST;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL RESPONSE MODIFIERS;
BREAST NEOPLASMS;
HUMANS;
IMMUNOTHERAPY;
|
|
EID: 0032845570
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (35)
|
|
References (149)
|
